Secondary acute lymphoblastic leukaemia in a multiple myeloma patient

Por Piszcz, Jaroslaw, Bolkun, Lukasz, Cichocka, Edyta, Kloczko, Janusz
Publicado em 2013

The role of Interleukin-17A and Interleukin-17E in multiple myeloma patients

Por Lemancewicz, Dorota, Bolkun, Lukasz, Jablonska, Ewa, Czeczuga-Semeniuk, Ewa, Kostur, Agnieszka, Kloczko, Janusz, Dzieciol, Janusz
Publicado em 2012

Involvement of BAFF and APRIL in Resistance to Apoptosis of Acute Myeloid Leukemia

Por Bolkun, Lukasz, Grubczak, Kamil, Schneider, Gabriela, Zembko, Paula, Radzikowska, Urszula, Singh, Paulina, Kloczko, Janusz, Ratajczak, Mariusz Z., Moniuszko, Marcin, Eljaszewicz, Andrzej
Publicado no J Cancer (2016)

To treat or not to treat: metabolomics reveals biomarkers for treatment indication in chronic lymphocytic leukaemia patients

Por Piszcz, Jaroslaw, Armitage, Emily G., Ferrarini, Alessia, Rupérez, Francisco J., Kulczynska, Agnieszka, Bolkun, Lukasz, Kloczko, Janusz, Kretowski, Adam, Urbanowicz, Alina, Ciborowski, Michal, Barbas, Coral
Publicado no Oncotarget (2016)

Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemia

Por Robak, Tadeusz, Hellmann, Andrzej, Kloczko, Janusz, Loscertales, Javier, Lech‐Maranda, Ewa, Pagel, John M., Mato, Anthony, Byrd, John C., Awan, Farrukh T., Hebart, Holger, Garcia‐Marco, Jose A., Hill, Brian T., Hallek, Michael, Eisenfeld, Amy J., Stromatt, Scott C., Jaeger, Ulrich
Publicado no Br J Haematol (2016)